Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
125I-insulin + H2O
?
-
-
-
-
?
2-Aminobenzoyl-Gly-Phe-Arg-Leu-Leu 4-nitrobenzyl amide + H2O
?
2-Aminobenzoyl-Gly-Phe-Arg-Xaa 4-nitrobenzyl amide + H2O
?
2-aminobenzoyl-KLCSSKQ-N-(2,4-dinitrophenyl)ethylenediamine + H2O
2-aminobenzoyl-KLC + SSKQ-N-(2,4-dinitrophenyl)ethylenediamine
-
-
-
-
?
2-aminobenzoyl-KLKSSKQ-N-(2,4-dinitrophenyl)ethylenediamine + H2O
2-aminobenzoyl-KLK + SSKQ-N-(2,4-dinitrophenyl)ethylenediamine
-
-
-
-
?
2-aminobenzoyl-KLRSSKQ-N-(2,4-dinitrophenyl)ethylenediamine + H2O
2-aminobenzoyl-KLR + SSKQ-N-(2,4-dinitrophenyl)ethylenediamine
-
-
-
-
?
Abz-LGMISLMKRPPGFSPFRSSRI-NH2 + H2O
?
-
peptide corresponds to fragment L373-I393 of human kininogen, cleavage of Arg-Ser, Gly-Phe and Lys-Arg bond
-
-
?
Ac-Pro-Leu-Gly-[2-mercapto-4-methylpentanoyl]-Leu-Gly-OEt + H2O
?
-
-
-
-
?
Aminoethylated lysozyme + H2O
?
-
-
-
-
?
angiotensin I + H2O
DRVY + IHPFLHL + DRVYI + HPFHL
-
-
-
?
angiotensin II + H2O
?
-
-
-
?
Azocoll + H2O
?
-
-
-
-
?
Benzyloxycarbonyl tripeptides + H2O
?
-
overview
-
-
?
Benzyloxycarbonyl-Ala-Ala-Ala + H2O
?
Benzyloxycarbonyl-Ala-Gly-Gly-Leu + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Ala-Gly-Gly-Leu-Ala + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Ala-Gly-Gly-Leu-Xaa + H2O
?
-
a hydrophobic or bulky residue at P3' results in marked increase in hydrolysis
-
-
?
benzyloxycarbonyl-Ala-Gly-Leu-Ala + H2O
?
-
-
-
-
?
benzyloxycarbonyl-Ala-Leu-Ala + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Ala-Phe-Gly-Ala + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Ala-Phe-Leu-Ala + H2O
?
-
-
-
-
?
benzyloxycarbonyl-D-Ala-Gly-Leu-Ala + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Gly-Ala-Ala + H2O
?
Benzyloxycarbonyl-Gly-Gly-Gly-Leu + H2O
?
-
poor substrate
-
-
?
Benzyloxycarbonyl-Gly-Gly-Leu amide + H2O
?
-
poor substrate
-
-
?
benzyloxycarbonyl-Gly-Gly-Leu-Ala + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Gly-Leu-Ala + H2O
?
-
-
-
-
?
benzyloxycarbonyl-Gly-Leu-Gly-Ala + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Gly-Leu-Gly-Gly + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Gly-Leu-Gly-Gly-Ala + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Gly-Leu-Gly-Gly-Xaa + H2O
?
-
a hydrophobic or bulky residue at P3' results in marked increase in hydrolysis
-
-
?
Benzyloxycarbonyl-Gly-Leu-Leu + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Gly-Leu-Phe + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Gly-Leu-Xaa + H2O
?
-
at position Xaa with decreasing susceptibility to the enzyme: Leu, Phe or Ala, poor substrates: Gly or NH2, D-Ala
-
-
?
Benzyloxycarbonyl-Gly-Pro-Gly-Gly-Pro-Ala + H2O
?
-
-
-
-
?
benzyloxycarbonyl-L-Arg-L-Arg-4-nitroanilide + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Phe-Ala-Ala + H2O
?
Benzyloxycarbonyl-Phe-Arg 4-methylcoumarin 7-amide + H2O
Benzyloxycarbonyl-Phe-Arg + 7-amino-4-methylcoumarin
benzyloxycarbonyl-Phe-Gly-Ala + H2O
?
-
-
-
-
?
benzyloxycarbonyl-Phe-Gly-Leu-Ala + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Phe-Leu-Ala-Ala + H2O
?
-
best substrate
-
-
?
benzyloxycarbonyl-Phe-Phe-Ala + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Phe-Xaa-Ala + H2O
Benzyloxycarbonyl-Phe + Xaa-Ala
-
susceptibility to the enzyme is Xaa-dependent, in decreasing order of efficiency: Ala, Phe, Leu, Trp or Ser or Gly
-
?
benzyloxycarbonyl-Val-Ala-Ala + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Xaa-Ala-Ala + H2O
Benzyloxycarbonyl-Xaa + Ala-Ala
-
susceptibility to the enzyme is Xaa-dependent, in decreasing order of efficiency: L-Phe, Leu or Ala, Val, Gly, D-Ala
-
?
Benzyloxycarbonyl-Xaa-Gly-Leu-Ala + H2O
?
-
a hydrophobic or bulky residue at P2 results in marked increase in hydrolysis
-
-
?
Benzyloxycarbonyl-Xaa-Leu-Ala + H2O
Benzyloxycarbonyl-Xaa + Leu-Ala
-
susceptibility to the enzyme is Xaa-dependent, in decreasing order of efficiency: L-Phe, Leu or Ala, Val, Gly, D-Ala
-
?
Benzyloxycarbonyl-Xaa-Phe-Gly-Ala + H2O
?
-
a hydrophobic or bulky residue at P2 results in marked increase in hydrolysis
-
-
?
Benzyloxycarbonyl-Xaa-Phe-Leu-Ala + H2O
?
-
a hydrophobic or bulky residue at P2 results in marked increase in hydrolysis
-
-
?
beta-1,3 glucan recognition protein 2 + H2O
?
-
identified target by in vitro exposure of hemolymph to PrtA
-
-
?
Boc-Gln-Ala-Arg-7-amido-4-methylcoumarin + H2O
?
-
-
-
-
?
Boc-Leu-Ser-Thr-Arg-7-amido-4-methylcoumarin + H2O
?
Boc-Val-Leu-Lys-7-amido-4-methylcoumarin + H2O
?
Boc-Val-Pro-Arg-7-amido-4-methylcoumarin + H2O
?
Bovine serum albumin + H2O
?
C-terminal octapeptide of glucagon + H2O
?
-
cleavage sites
-
-
?
Carboxymethyl-beta-insulin + H2O
?
-
cleavage sites
-
-
?
D-Ala-Leu-Lys-7-amido-4-methylcoumarin + H2O
?
-
-
-
-
?
Dabcyl-Glu-Val-Tyr-Ala-Val-Glu-Ser-EDANS + H2O
?
-
-
-
-
?
DL-Val-Leu-Arg-4-nitroanilide + H2O
?
-
-
-
-
?
Egg albumin + H2O
?
-
-
-
-
?
Fibronectin + H2O
?
-
-
-
?
furylacryloyl-Ala-Leu-Val-Tyr + H2O
?
-
-
-
-
?
furylacryloyl-Leu-Gly-Pro-Ala + H2O
?
-
-
-
-
?
Glucagon + H2O
?
-
cleavage sites
-
-
?
Glycoprotein G + H2O
?
-
i.e. thrombin-sensitive protein, thrombospondin, MW 190000
-
-
?
hemocyte aggregation inhibitor protein (HAIP) + H2O
?
-
identified target by in vitro exposure of hemolymph to PrtA
-
-
?
hide powder azure + H2O
?
-
-
-
-
?
His-Ser-4-methoxy-2-naphthylamide + H2O
?
-
-
-
-
?
His-Ser-4-methoxy-2-naphthylamide + H2O
His-Ser + 4-methoxy-2-naphthylamine
-
-
-
-
?
Human alpha1-proteinase inhibitor + H2O
?
-
MW 52000
-
-
?
human complement component C1 + H2O
?
-
-
-
-
?
human complement component C2 + H2O
?
-
-
-
-
?
Human platelet surface glycoprotein Ib + H2O
?
-
-
-
-
?
Immunoglobulin A1 + H2O
?
-
Serratia marcescens, MW 56000 enzyme, predominantly interdomain cleavage at hinge region
-
-
?
Immunoglobulin A2 + H2O
?
-
Serratia marcescens, MW 56000 enzyme, predominantly interdomain cleavage at hinge region
-
-
?
Immunoglobulin G1 + H2O
?
-
Serratia marcescens, MW 56000 enzyme, predominantly interdomain cleavage at hinge region
-
-
?
Immunoglobulin G2 + H2O
?
-
Serratia marcescens, MW 56000 enzyme, predominantly interdomain cleavage at hinge region
-
-
?
Immunoglobulin G3 + H2O
?
-
Serratia marcescens, MW 56000 enzyme, predominantly interdomain cleavage at hinge region
-
-
?
Immunoglobulin G4 + H2O
?
-
Serratia marcescens, MW 56000 enzyme, predominantly interdomain cleavage at hinge region
-
-
?
including serpin-1I + H2O
?
-
identified target by in vitro exposure of hemolymph to PrtA
-
-
?
interleukin-6 + H2O
?
-
complete digestion
-
-
?
interleukin-8 + H2O
?
-
rapid processing to a 72 amino acid form, further degradation is slow
-
-
?
L-Ala-L-Ala-L-Ala-L-Ala + H2O
L-Ala-L-Ala + L-Ala-L-Ala
-
-
-
?
L-Ala-L-Ala-L-Ala-L-Ala-L-Ala + H2O
L-Ala-L-Ala + L-Ala-L-Ala-L-Ala
-
-
-
?
L-Ala-L-Ala-L-Ala-L-Ala-L-Ala-L-Ala + H2O
L-Ala-L-Ala-L-Ala + L-Ala-L-Ala-L-Ala
-
-
-
?
L-Ala-oligopeptides + H2O
?
-
proteolytic activity increases drastically with increasing chain length from tetramer to hexamer, no substrate: dipeptide or tripeptide
-
-
?
L-Ser-7-amido-4-methylcoumarin + H2O
L-Ser + 7-amino-4-methylcoumarin
N-alpha-benzoyl-DL-arginine-p-nitroanilide + H2O
N-alpha-benzoyl-DL-arginine + 4-nitroaniline
-
artificial substrate BAPNA
-
?
N-benzyloxycarbonyl-Gly-Gly-Arg-7-amido-4-methylcoumarin + H2O
?
-
-
-
-
?
N-terminal hexapeptide of glucagon + H2O
?
-
cleavage sites
-
-
?
o-aminobenzoyl-KDRFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine + H2O
o-aminobenzoyl-KDR + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine
-
-
-
-
?
o-aminobenzoyl-KDRFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KDR + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KFRFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KFR + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KGRFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KGR + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KHRFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KHR + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLAFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLA + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLDFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLD + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLEFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLE + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLFFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLF + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLGFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLG + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLHFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLH + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLKFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLK + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLLFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLL + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLMFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLM + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLNFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLN + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLPFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLP + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLQFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLQ + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLRASKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLR + ASKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLRDSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLR + DSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLRFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLR + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLRLSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLR + LSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLRNSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLR + NSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLRRSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLR + RSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLRSSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLR + SSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine
-
-
-
-
?
o-aminobenzoyl-KLSFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLS + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLTFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLT + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLWFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLW + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KLYFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KLY + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KNRFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KNR + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KQRFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KQR + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KRRFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KRR + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
o-aminobenzoyl-KSRFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine) + H2O
o-aminobenzoyl-KSR + FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
-
-
?
Oxidized insulin B-chain + H2O
?
peptide 6A + H2O
?
-
-
-
?
Phe-Gly-Leu-Ala + H2O
?
-
-
-
-
?
Plasma fibronectin + H2O
?
Pro-Phe-Arg 4-methylcoumarin 7-amide + H2O
Pro-Phe-Arg + 7-amino-4-methylcoumarin
Pro-Phe-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
Ribonuclease + H2O
?
-
-
-
-
?
scolexins A + H2O
?
-
identified target by in vitro exposure of hemolymph to PrtA
-
-
?
scolexins B + H2O
?
-
identified target by in vitro exposure of hemolymph to PrtA
-
-
?
serine proteinase homolog 3 + H2O
?
-
identified target by in vitro exposure of hemolymph to PrtA
-
-
?
serpin-1 variants + H2O
?
-
identified target by in vitro exposure of hemolymph to PrtA, six serpin-1 variants differing in their 40- to 50-amino-acid-long C-terminal sequences are identified
-
-
?
substance P + H2O
RPKPQQFFG + LM-NH2 + RPKPQQFF + GLM-NH2 + RPKQQF + FGLM-NH2
-
-
-
?
substance P 1-7 + H2O
?
-
-
-
?
substance P 1-9 + H2O
RPKP + QQFFG + RPKQQ + FFG
-
-
-
?
substance P 7-11 + H2O
?
-
-
-
?
substance P 8-11 + H2O
?
-
-
-
?
substance P(free acid) + H2O
RPKPQQFFG + LM + RPKPQQFF + GLM + RPKQQF + FGLM
-
-
-
?
Suc-Leu-Leu-Val-Tyr-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
Succ-Ala-Ala-Pro-Phe-thiobenzyl ester + H2O
?
-
-
-
-
?
Succ-Ala-Ala-Pro-Xaa-7-amido-4-methylcoumarin + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Ala-Gly-Pro-Arg-4-methylcoumaryl-7-amide + H2O
?
t-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide + H2O
?
t-butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Gln-Arg-Arg-4-methylcoumaryl-7-amide + H2O
?
t-butyloxycarbonyl-Glu-Lys-Lys-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Gly-Arg-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Gly-Lys-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Leu-Arg-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Leu-Lys-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Leu-Ser-Thr-Arg-4-methylcoumaryl-7-amide + H2O
?
t-butyloxycarbonyl-Met-Thr-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Phe-Ser-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Val-Leu-Lys-4-methylcoumaryl-7-amide + H2O
?
t-butyloxycarbonyl-Val-Pro-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
Tryptic insulin heptapeptide + H2O
?
-
cleavage sites
-
-
?
additional information
?
-
2-Aminobenzoyl-Gly-Phe-Arg-Leu-Leu 4-nitrobenzyl amide + H2O
?
-
Pseudomonas aeruginosa alkaline proteinase and MW 52000 Serratia enzyme
-
-
?
2-Aminobenzoyl-Gly-Phe-Arg-Leu-Leu 4-nitrobenzyl amide + H2O
?
-
Pseudomonas aeruginosa alkaline proteinase and MW 52000 Serratia enzyme
-
-
?
2-Aminobenzoyl-Gly-Phe-Arg-Xaa 4-nitrobenzyl amide + H2O
?
-
Xaa is Gly, Ala, Val, Leu or Phe, Pseudomonas aeruginosa alkaline proteinase and MW 52000 Serratia enzyme
-
-
?
2-Aminobenzoyl-Gly-Phe-Arg-Xaa 4-nitrobenzyl amide + H2O
?
-
Xaa is Gly, Ala, Val, Leu or Phe, Pseudomonas aeruginosa alkaline proteinase and MW 52000 Serratia enzyme
-
-
?
azocasein + H2O
?
-
-
-
-
?
azocasein + H2O
?
-
-
-
-
?
azocasein + H2O
?
-
-
-
-
?
azocasein + H2O
?
-
-
-
-
?
azocasein + H2O
?
-
-
-
-
?
azocasein + H2O
?
-
-
-
?
azocasein + H2O
?
-
-
-
-
?
azocasein + H2O
?
-
-
-
-
?
azocasein + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Ala-Ala-Ala + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Ala-Ala-Ala + H2O
?
-
cleavage site: AlaÄ+ÄAla-Ala
-
-
?
Benzyloxycarbonyl-Gly-Ala-Ala + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Gly-Ala-Ala + H2O
?
-
cleavage site: Gly-Ala
-
-
?
Benzyloxycarbonyl-Phe-Ala-Ala + H2O
?
-
-
-
-
?
Benzyloxycarbonyl-Phe-Ala-Ala + H2O
?
-
cleavage site: Phe-Ala
-
-
?
Benzyloxycarbonyl-Phe-Arg 4-methylcoumarin 7-amide + H2O
Benzyloxycarbonyl-Phe-Arg + 7-amino-4-methylcoumarin
-
Pseudomonas aeruginosa alkaline proteinase and MW 52000 Serratia enzyme
-
?
Benzyloxycarbonyl-Phe-Arg 4-methylcoumarin 7-amide + H2O
Benzyloxycarbonyl-Phe-Arg + 7-amino-4-methylcoumarin
-
Pseudomonas aeruginosa alkaline proteinase and MW 52000 Serratia enzyme
-
?
Boc-Leu-Ser-Thr-Arg-7-amido-4-methylcoumarin + H2O
?
-
-
-
-
?
Boc-Leu-Ser-Thr-Arg-7-amido-4-methylcoumarin + H2O
?
-
-
-
-
?
Boc-Val-Leu-Lys-7-amido-4-methylcoumarin + H2O
?
-
-
-
-
?
Boc-Val-Leu-Lys-7-amido-4-methylcoumarin + H2O
?
-
-
-
-
?
Boc-Val-Pro-Arg-7-amido-4-methylcoumarin + H2O
?
-
-
-
-
?
Boc-Val-Pro-Arg-7-amido-4-methylcoumarin + H2O
?
-
-
-
-
?
Bovine serum albumin + H2O
?
-
the enzyme cleaves 61 unique sequence pairs of bovine serum albumin involving all 20 amino acids
-
-
?
Bovine serum albumin + H2O
?
-
the enzyme cleaves 61 unique sequence pairs of bovine serum albumin involving all 20 amino acids
-
-
?
casein + H2O
?
-
-
-
-
?
casein + H2O
?
-
Km of 1.261 mg/ml for casein
-
-
?
casein + H2O
?
-
Km of 1.261 mg/ml for casein
-
-
?
Fibrin + H2O
?
-
-
-
-
?
Fibrinogen + H2O
?
-
-
-
-
?
Fibrinogen + H2O
?
-
the enzyme hydrolyzes the Aalpha chain in 1 min, the Bbeta chain in 5 min, and the gamma chain in more than 1 h
-
-
?
Fibrinogen + H2O
?
-
the enzyme hydrolyzes the Aalpha chain in 1 min, the Bbeta chain in 5 min, and the gamma chain in more than 1 h
-
-
?
Gelatin + H2O
?
-
-
-
-
?
Gelatin + H2O
?
-
-
-
-
?
Gelatin + H2O
?
-
-
-
-
?
Gelatin + H2O
?
-
-
-
-
?
Hemoglobin + H2O
?
-
-
-
-
?
Hemoglobin + H2O
?
-
-
-
-
?
L-Ser-7-amido-4-methylcoumarin + H2O
L-Ser + 7-amino-4-methylcoumarin
-
-
-
-
?
L-Ser-7-amido-4-methylcoumarin + H2O
L-Ser + 7-amino-4-methylcoumarin
-
-
-
-
?
Oxidized insulin B-chain + H2O
?
-
cleavage specificity of Pseudomonas aeruginosa, Pseudomonas fragi, Serratia sp. and Proteus mirabilis enzyme
-
-
?
Oxidized insulin B-chain + H2O
?
-
cleavage sites
-
-
?
Oxidized insulin B-chain + H2O
?
-
cleavage specificity of Pseudomonas aeruginosa, Pseudomonas fragi, Serratia sp. and Proteus mirabilis enzyme
-
-
?
Oxidized insulin B-chain + H2O
?
-
cleavage specificity of Pseudomonas aeruginosa, Pseudomonas fragi, Serratia sp. and Proteus mirabilis enzyme
-
-
?
Oxidized insulin B-chain + H2O
?
-
cleavage specificity of Pseudomonas aeruginosa, Pseudomonas fragi, Serratia sp. and Proteus mirabilis enzyme
-
-
?
Plasma fibronectin + H2O
?
-
Serratia marcescens MW 52000 enzyme, cleavage sites
-
-
?
Plasma fibronectin + H2O
?
-
from pig
-
-
?
Pro-Phe-Arg 4-methylcoumarin 7-amide + H2O
Pro-Phe-Arg + 7-amino-4-methylcoumarin
-
Pseudomonas aeruginosa alkaline proteinase and MW 52000 Serratia enzyme
-
?
Pro-Phe-Arg 4-methylcoumarin 7-amide + H2O
Pro-Phe-Arg + 7-amino-4-methylcoumarin
-
Pseudomonas aeruginosa alkaline proteinase and MW 52000 Serratia enzyme
-
?
t-butyloxycarbonyl-Ala-Gly-Pro-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Ala-Gly-Pro-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Arg-Val-Arg-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Gln-Arg-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Gln-Arg-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Leu-Ser-Thr-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Leu-Ser-Thr-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Leu-Ser-Thr-Arg-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Val-Leu-Lys-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Val-Leu-Lys-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
t-butyloxycarbonyl-Val-Leu-Lys-4-methylcoumaryl-7-amide + H2O
?
-
-
-
-
?
additional information
?
-
-
no substrate: casein, bovine serum albumin, lysozyme, lactalbumin, lactoglobulin and thyroglobulin
-
-
?
additional information
?
-
-
elastin
-
-
?
additional information
?
-
-
elastin
-
-
?
additional information
?
-
-
broad substrate side-chain specificity: hydrophobic amino acid residues at P2 and P2' are favorable
-
-
?
additional information
?
-
-
benzoyl-L-Arg amide, acetyl-L-Tyr ethyl ester, carbobenzoxy-Glu-Tyr, carbobenzoxy-Gly-Phe, L-Leu amide
-
-
?
additional information
?
-
-
collagen
-
-
?
additional information
?
-
-
tetrapeptides are poorer substrates than benzyloxycarbonyl tetrapeptides
-
-
?
additional information
?
-
-
benzyloxycarbonyl dipeptides, N-acetylated amino acid esters or amides, dipeptide amides, tripeptides, benzyloxycarbonyl-(Gly)4, benzyloxycarbonyl-(Gly)5, benzyloxycarbonyl-Gly-Leu-Gly-Gly-D-Ala
-
-
?
additional information
?
-
-
inhibits cytokine-induced signaling in A549 pulmonary epithelial cells
-
-
?
additional information
?
-
-
inhibits IFN-gamma antiviral and immunomodulatory activity
-
-
?
additional information
?
-
-
-
-
-
?
additional information
?
-
-
no substrates are small peptides
-
-
?
additional information
?
-
-
human platelet surface glycoprotein V
-
-
?
additional information
?
-
-
minimum peptide size: hexapeptide
-
-
?
additional information
?
-
-
trypsin-alpha1-proteinase inhibitor complex
-
-
?
additional information
?
-
-
no esterase activity: no substrates are N-benzoyl-L-Arg ethyl ester or N-benzoyl-L-Tyr ethyl esters
-
-
?
additional information
?
-
-
important factor in virulence seen in several microbial diseases caused by Pseudomonas aeruginosa and Serratia marcescens, e.g. corneal ulcers and pneumonia, inducible enzyme
-
-
?
additional information
?
-
-
the enzyme does not degrade urokinase, streptokinase, and tissue plasminogen activator
-
-
?
additional information
?
-
-
the enzyme does not degrade urokinase, streptokinase, and tissue plasminogen activator
-
-
?
additional information
?
-
-
S1 subsite has a broad specificity, being Gly the preferred amino acid followed by positively charged residues Arg and His. S2 and S1' subsites accomodate better hydrophilic residues with aliphatic or aromatic side chains like Leu or Phe
-
-
-
additional information
?
-
-
enzyme prefers Arg in subsite P1
-
-
?
additional information
?
-
-
substrate specificity, and reaction product analysis by electron-spray ionization mass spectrometry, overview. Protease B requires at least three amino acids N-terminal to the scissile bond for detectable hydrolysis. On such substrate protease B is clearly specific for positively charged residues, Arg and Lys, at the P1 substrate position and is rather permissive in the others, but Ser at P1 is preferred in the oligopeptide substrate which contained amino acids also C-terminal to the scissile bond
-
-
?
additional information
?
-
-
substrate specificity, and reaction product analysis by electron-spray ionization mass spectrometry, overview. Protease B requires at least three amino acids N-terminal to the scissile bond for detectable hydrolysis. On such substrate protease B is clearly specific for positively charged residues, Arg and Lys, at the P1 substrate position and is rather permissive in the others, but Ser at P1 is preferred in the oligopeptide substrate which contained amino acids also C-terminal to the scissile bond
-
-
?